Ovitrelle is a medicine used in women undergoing artificial insemination, conventional IVF, and ICSI in order to become pregnant.

The recommended dose of Ovitrelle varies depending on the final goal.

Usage in assisted reproductive techniques

In women undergoing a controlled ovarian stimulation prior to assisted reproductive techniques, such as in vitro fertilisation (IVF), one prefilled syringe of Ovitrelle (250 micrograms) must be injected 24 to 48 hours after the last administration of a follicle stimulating hormone (FSH) or human menopausal gonadotropin (hMG) preparation.

It’s important to follow the doctor’s indications and administer it in the right moment, because once the optimal stimulation of follicle development has been achieved, the follicles are prepared so that it is easier to perform the oocyte extraction.

Administration of Ovitrelle

Usage for anovulation

Ovitrelle can be administered to women with ovulatory alterations, be it anovulation (absence of ovulation) or oligo-ovulation (in which the ovulations don’t take place normally).

One prefilled syringe of Ovitrelle (250 micrograms) must be administered 24 to 48 hours after optimal stimulation of follicular growth is achieved.

Medicinal product subject to medical prescription.The information here published does not substitute, under any circumstances, the doctor’s instructions. Before using the medication, the information pamphlet must be read.

Cookies allow us to show customized advertising and collect statistical data. By continuing to use our website, you are agreeing to our cookies policy.